ArtusLabs and Viamet Pharmaceuticals Collaborate to Develop Metallobase(TM)

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--ArtusLabs, Inc. (www.artuslabs.com), the leader in scientifically-aware data management systems, and Viamet Pharmaceuticals, Inc. (www.viamet.com), a human therapeutic company focused on “best-in-class” metalloenzyme inhibitors, today announced the collaborative development of Metallobase™, Viamet Pharmaceuticals’ proprietary database of metalloenzymes and metalloenzyme inhibitors.